Squarepoint Ops LLC Athenex, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.79 - $1.59 $13,013 - $26,192	-16,473 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $51,578 - $111,499	-37,925 Reduced 69.72%	16,473 $22,000
Q3 2021 Nov 15, 2021	SELL	$2.97 - $4.84 $340,370 - $554,678	-114,603 Reduced 67.81%	54,398 $164,000
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.13 $207,018 - $286,254	55,800 Added 49.29%	169,001 $781,000
Q1 2021 May 17, 2021	SELL	$4.08 - $14.75 $1,599 - $5,782	-392 Reduced 0.35%	113,201 $487,000
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $1.02 Million - $1.3 Million	92,532 Added 439.35%	113,593 $1.26 Million
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $216,085 - $306,437	21,061 New	21,061 $255,000
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $544,163 - $1.05 Million	-76,535 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$5.71 - $15.85 $549,644 - $1.53 Million	-96,260 Reduced 55.71%	76,535 $592,000
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $1.41 Million - $2.61 Million	147,113 Added 572.83%	172,795 $2.64 Million
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $45,527 - $78,624	3,744 Added 17.07%	25,682 $312,000
Q2 2019 Aug 14, 2019	SELL	$9.44 - $19.8 $20,749 - $43,520	-2,198 Reduced 9.11%	21,938 $434,000
Q1 2019 May 15, 2019	SELL	$11.11 - $13.49 $506,438 - $614,928	-45,584 Reduced 65.38%	24,136 $296,000
Q4 2018 Feb 14, 2019	BUY	$10.24 - $15.49 $15,298 - $23,142	1,494 Added 2.19%	69,720 $885,000
Q3 2018 Nov 14, 2018	BUY	$15.53 - $19.97 $643,345 - $827,277	41,426 Added 154.57%	68,226 $1.06 Million
Q2 2018 Aug 14, 2018	BUY	$15.88 - $19.5 $425,584 - $522,600	26,800 New	26,800 $500,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account